Skip to main content
. 2020 Dec 2;5(1):bjgpopen20X101122. doi: 10.3399/bjgpopen20X101122

Table 2. Daily OMEQe (mg) issued on prescription, given as annual totals and adjusted to population, stratified by drug.

Oral or transdermal opioids
Total daily OMEQe (mg) dose prescribed Annual total daily OMEQe dose (mg) per 1000 population OMEQe dose (mg) per prescription issued Annual number of prescriptions issued per 1000 population
Buprenorphine 23 641 528
 2005 977 464 422 98 4
 2015 2 756 458 1142 37 31
 Rate change, % 182 170.5 –61.7 606.3
Codeine 223 817 156
 2005 13 743 115 5916 17 357
 2015 25 593 382 10 581 19 549
 Rate change, % 86.2 78.8 16.2 53.9
Dihydrocodeine 44 600 874
 2005 4 368 806 1887 12 154
 2015 3 471 460 1438 13 109
 Rate change, % –20.5 –23.8 7.7 –29.2
Fentanyl 64 138 905
 2005 2 695 290 1164 186 6
 2015 6 496 270 2691 147 18
 Rate change, % 141.0 131.2 –21.2 193.2
Morphine 91 132 530
 2005 3 293 220 1422 86 17
 2015 17 047 800 7063 68 104
 Rate change, % 417.7 396.6 –20.6 525.6
Oxycodone 45 120 680
 2005 1 316 480 569 105 5
 2015 6 165 400 2554 100 26
 Rate change, % 368.3 349.3 –4.9 372.4
Tramadol 144 173 635
 2005 7 865 695 3397 36 95
 2015 14 252 335 5905 38 156
 Rate change, % 81.2 73.8 5.7 64.4
Other 8 888 696
 2005 3 446 735 1719 27 56
 2015 699 711 347 58 5
 Rate change, % –79.7 –79.8 117.4 –91.0

Results are rounded to nearest whole number. Rate change (%) calculated using original, unrounded data. Original data are available from the authors on request.